Business Context and Reporting Period
This Form 8-K was filed by Oculus Innovative Sciences, Inc. on March 6, 2013, reporting an underwritten public offering of common stock. The company is incorporated in Delaware and headquartered in Petaluma, California.
Key Financial Metrics and Transaction Details
- Offering Size: 7,500,000 shares of common stock at $0.40 per share.
- Gross Proceeds: Approximately $3.0 million (or approximately $3.45 million if the over-allotment option is fully exercised).
- Over-Allotment Option: Underwriters granted a 45-day option to purchase up to 1,125,000 additional shares.
- Underwriters Warrants: 375,000 warrants issued to underwriters with an exercise price of $0.50 (125% of public offering price), exercisable from March 12, 2014, through March 12, 2016.
- Use of Proceeds: General corporate purposes, including repayment of certain indebtedness and retirement of common stock held by lenders.
- Closing Date: Expected on or about March 12, 2013.
Material Changes
The filing announces a material capital event: the commencement and pricing of a public equity offering. This represents a significant change in the company's capital structure and liquidity position compared to the prior period, though specific prior period financial metrics are not provided in this document.
Outlook, Risks, and Management Commentary
Management intends to use the net proceeds to reduce debt and retire lender-held shares. The filing includes standard forward-looking statements regarding future activities and a planned spin-off of a separate public company. Risks include uncertainties associated with the spin-off and the Board's discretion to delay or cancel it. The filing notes that actual results may differ materially from expectations due to various factors detailed in the company's Form 10-K.
Investor Verification Checklist
- Verify the final closing date and actual gross proceeds received after deducting underwriting discounts and offering expenses.
- Confirm the specific amount of indebtedness to be repaid and the number of shares to be retired from lenders.
- Review the full text of the Underwriting Agreement (Exhibit 1.1) for specific representations, warranties, and termination provisions.
- Monitor the status of the planned spin-off mentioned in the forward-looking statements.
- Check if the underwriters exercised the 45-day over-allotment option.